Clinical Utility: A small number of patients having early onset or ocular restricted MG may only have AChR modulating autoantibodies; therefore, if AChR binding autoantibodies are absent in a patient with weakness or ocular symptoms consistent with MG, AChR modulating autoantibodies should be ordered.
Serum (1 mL)
Ambient 14 Days
Refrigerated 14 Days
Frozen 30 Days
Enter your information below